SEC Form 4 · accession 0001209191-18-033874
Iterum Therapeutics plc · ITRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shahzad Malik
Director
Period of report
May 24, 2018
Accepted (ET)
May 29, 2018 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001659323
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $13.00 | May 24, 2018 | A | 11,241 | A | — | May 23, 2028 | Ordinary Shares | 11,241 | 11,241 | D |
Explanation of responses
- F1Subject to the Reporting Person providing continuous service, the shares subject to this option shall vest on May 24, 2019.